Bopedacol injection, which once became the most expensive drug in China at a price of 2.79 million yuan per dose, finally welcomed the first patient to use it after reducing the price by 1.4 million yuan in June of this year. On September 9, the reporter learned from the R&D manufacturer Xinji Pharmaceutical that Xinjiuning recently issued the country's first prescription in Tianjin. Xinjiuning is a gene therapy for moderate to severe hemophilia B. It was independently developed by a Chinese company. It is also the first adeno-associated virus vector gene therapy to be marketed domestically. It was approved for sale in China in April 2025.
Zhitongcaijing · 1d ago
Share
Listen to the news
Bopedacol injection, which once became the most expensive drug in China at a price of 2.79 million yuan per dose, finally welcomed the first patient to use it after reducing the price by 1.4 million yuan in June of this year. On September 9, the reporter learned from the R&D manufacturer Xinji Pharmaceutical that Xinjiuning recently issued the country's first prescription in Tianjin. Xinjiuning is a gene therapy for moderate to severe hemophilia B. It was independently developed by a Chinese company. It is also the first adeno-associated virus vector gene therapy to be marketed domestically. It was approved for sale in China in April 2025.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending